TSS
REVBW icon

Two Sigma Securities’s Revelation Biosciences Warrant REVBW Stock Holding History

Two Sigma Securities’s Portfolio REVBW Stock Details REVBW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,354
Closed -$72 – 2075
2024
Q4 		$72 Sell
10,354
-5,460
-35% -$64 ﹤0.01% 1542
2024
Q3 		$237 Buy
+15,814
New +$221 ﹤0.01% 2752

Other funds holding REVBW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PIS
POM Investment Strategies Raleigh, North Carolina $80.5M AUM 16.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's REVBW Position: Q1 2025 in Review

Two Sigma Securities sold out of Revelation Biosciences Warrant (REVBW) in Q1 2025, closing a stake of 10,354 shares — an estimated $72 sold.

Two Sigma Securities first reported a position in REVBW in Q3 2024 and held it in 2 quarters. The position peaked at $237 in Q3 2024. 9 funds tracked by Wall St. Rank hold REVBW as of Q1 2025.

  • Two Sigma Securities reported no remaining Revelation Biosciences Warrant position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 10,354 Revelation Biosciences Warrant shares in Q1 2025, an estimated $72.
  • Two Sigma Securities first reported a position in Revelation Biosciences Warrant in Q3 2024 and held it in 2 quarters.
  • Two Sigma Securities's Revelation Biosciences Warrant position peaked at $237 in Q3 2024.
  • 9 funds tracked by Wall St. Rank held Revelation Biosciences Warrant as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.